FENC - CIK 0001211583
The table below shows FENNEC PHARMACEUTICALS INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $36.79M | $26.63M | $13.27M | $23.77M | $21.10M | $30.34M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $67.04M |
| $44.12M |
| $26.86M |
| $26.73M |
| $22.39M |
| $31.42M |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $70.55M | $44.95M | $26.86M | $26.94M | $22.41M | $31.42M |
| Accounts payable | $4.63M | $3.24M | $3.78M | $2.39M | $777.00K | $1.57M |
| Total current liabilities | $10.52M | $6.92M | $7.55M | $4.61M | $1.65M | $2.35M |
| Long-term debt | - | $19.34M | $30.93M | $24.90M | - | - |
| Total liabilities | $35.08M | $50.82M | $38.49M | $29.51M | $6.64M | $2.35M |
| Retained earnings | -$229.42M | -$219.68M | -$219.25M | -$203.20M | -$179.49M | -$162.14M |
| Total equity | $35.47M | -$5.87M | -$11.62M | -$2.57M | $15.77M | $29.07M |